Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
Author:
Funder
Astellas Pharma Europe
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference53 articles.
1. Immunosuppression and other nonsurgical factors in the improved results of liver transplantation;TE Starzl;Semin Liver Dis,1985
2. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection;Lancet,1994
3. A comparison of tacrolimus (FK 506) and ciclosporin for immunosuppression in liver transplantation;N Engl J Med,1994
4. Randomized trial of ciclosporin microemulsion (neoral) versus conventional ciclosporin in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral;MG Otto;Transplantation,1998
5. A single-centre experience with ciclosporin microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety;C Loinaz;Transplant Proc,2001
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes;Annals of Gastroenterological Surgery;2024-01-19
2. Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial;The Lancet Respiratory Medicine;2024-01
3. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – a propensity score-matched intention-to-treat analysis;Journal of Hepatology;2024-01
4. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement;Transplant International;2023-09-29
5. Artificial Neural Network Analysis of Determinants of Tacrolimus Pharmacokinetics in Liver Transplant Recipients;Annals of Pharmacotherapy;2023-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3